Haplotypes of the plasminogen activator gene associated with ischemic stroke

Thrombosis and Haemostasis

Volumn 96, Issue 3, 2006, Pages 331-336

  Saito, Kosuke ^a,b   Nakayama, Tomohiro ^a   Sato, Naoyuki ^a   Morita, Akihiko ^a   Takahashi, Teruyuki ^c   Soma, Masayoshi ^a   Usami, Ron ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c NIHON UNIVERSITY   (Japan)

Author keywords

Association studies; Genetics; Haplotypes; Ischemic stroke; Tissue plasminogen activator

Indexed keywords

CYTOSINE; GUANINE; PLASMINOGEN ACTIVATOR; THREONINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; ISCHEMIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE; THROMBOSIS;

EID: 33748604555     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-12-0830     Document Type: Article

References (29)

1. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain 2000; 123: 1784-812.
2. Rubattu S, Di Angelantonio E, Nitsch D, et al. Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population. Thromb Haemost 2005; 93: 1095-100.
3. Ridker PM, Hennekens CH, Stampfer MJ, et al. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-3.
4. Pizzo SV, Petruska DB, Doman KA, et al. Releasable vascular plasminogen activator and thrombotic strokes. Am J Med 1985-1 79: 407-11.
5. Ridker PM, Vaughan DE, Stampfer MJ, et al. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
6. ECAT Angina Pectoris Study Group. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17.
7. Jansson JH, Nilsson TK, Olofsson BO. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J 199 1; 12: 157-61.
8. Degen SJ, Rajput B, Reich E. The human tissue plasminogen activator gene. J Biol Chem 1986; 25: 6972-85.
9. Jannes J, Hamilton-Bruce MA, Pilotto L, et al. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke 2004; 35: 1090-4.
10. Nakayama T, Asai S, Sato N, et al. Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese: a case-control study. Stroke 2006; 37: 69-76.
11. Sano M, Kuroi N, Nakayama T, et al. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens 2005; 18: 403-8.
12. Nakayama T, Soma M, Kammatsuse K, et al. The microsatellite alleles on chromosome 1 associated with essential hypertension and blood pressure levels. J Hum Hypertens 2004; 18: 823-8.
13. Zhang W, Collins A, Morton NE. Does haplotype diversity predict power for association mapping of disease susceptibility? Hum Genet 2004; 115: 157-64.
14. Nakayama T, Soma M, Sato N, et al. An association study in essential hypertension using functional polymorphisms in lymphotoxin-α gene. Am J Hypertens 2004; 17: 1045-9.
15. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from in complete data via the EM algorithm. J R Stat Soc 1977; 39: 1-22.
16. Hasimu B, Nakayama T, Mizutani Y, et al. Haplotype analysis of the Human Renin Gene and Essential Hypertension. Hypertension 2003; 41: 308-12.
17. Nakayama T, Soma M, Takahashi Y, et al. Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet 1997; 51: 26-30.
18. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988; 120: 849-52.
19. Taillon-Miller P, Bauer-Sardina I, Saccone NL, et al. Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet 2000; 25: 324-8.
20. Rubattu S, Volpe M, Kreutz R, et al. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. [Comment]. Nat Genet 1996; 13: 429-34.
21. Jood K, Ladenvall P, Tjarnlund-Wolf A, et al. Fibrinolytic gene polymorphism and ischemic stroke. Stroke 2005; 36: 2077-81.
22. Morris RW, Kaplan NL. On the advantage of haplotype-analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-33.
23. Joosten PH, Toepoel M, Mariman EC, et al. Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects. Nat Genet 2001; 27: 215-7.
24. Sharma P, Hingorani A, Jia H, et al. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension. J Hypertens 1999; 7: 1281-7.
25. Ombra MN, Forabosco P, Casula S, et al. Identification of a new candidate locus for uric acid nephrolithiasis. Am J Hum Genet 2001; 68: 1119-29.
26. Hasimu B, Nakayama T, Mizutani Y, et al. A novel variable number of tandem repeat polymorphism of the renin gene and essential hypertension. Hypertens Res 2003; 26: 473-7
27. Kumar NN, Benjafield AV, Lin RC, et al. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens 2003; 21: 1331-7.
28. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype, blocks in the human genome. Science 2002; 296: 2225-9.
29. Ladenvall P, Nilsson S, Jood K, et al. Genetic variation at the human tissue-type plasminogen activator (tPA) locus: haplotypes and analysis of association to plasma levels of tPA. Eur J Hum Genet 2003; 11: 603-10.